Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis.
about
The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled.Contribution of monoamine oxidases to vascular oxidative stress in patients with end-stage renal disease requiring hemodialysis.An evidence-based systematic review of the off-label uses of lisinoprilAntiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study
P2860
Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Angiotensin Converting-Enzyme ...... ients Undergoing Hemodialysis.
@ast
Angiotensin Converting-Enzyme ...... ients Undergoing Hemodialysis.
@en
type
label
Angiotensin Converting-Enzyme ...... ients Undergoing Hemodialysis.
@ast
Angiotensin Converting-Enzyme ...... ients Undergoing Hemodialysis.
@en
prefLabel
Angiotensin Converting-Enzyme ...... ients Undergoing Hemodialysis.
@ast
Angiotensin Converting-Enzyme ...... ients Undergoing Hemodialysis.
@en
P2093
P2860
P1433
P1476
Angiotensin Converting-Enzyme ...... ients Undergoing Hemodialysis.
@en
P2093
Chih-Chiang Chien
Chih-Ching Lin
Fu-An Chen
Yu-Wei Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0166362
P407
P577
2016-11-10T00:00:00Z